Literature DB >> 21505268

Assessment of glycemic lability and severity of hypoglycemia in Korean patients with type 1 diabetes.

Soo Kyoung Kim1, Soon Beom Kwon, Kun Ho Yoon, Kyu Jeung Ahn, Jun Goo Kang, Hye Seung Jung, Eun Seok Kang, Jae Hyeon Kim, Kwang-Won Kim.   

Abstract

Few studies have focused on the quantification of glycemic lability and hypoglycemic events in Asian patients with type 1 diabetes; therefore, we conducted a study to assess glycemic lability and the severity of hypoglycemia in type 1 diabetic patients in Korea. A total of 124 type 1 diabetic patients were enrolled. Several glycemic lability indexes and hypoglycemic indexes were calculated using four-week self-monitoring of blood glucose (SMBG) data. Due to the dependence of the lability index (LI) on the frequency of glucose measurements, we generated a modified LI by dividing by the number of SMBG measurements per day for a given patient. The numbers of patients in our study with a composite hypoglycemic score ≥ 1,047 or LI ≥ 433 mmol/L(2)/h•week(-1), which was found in a previous study to indicate high risk of severe hypoglycemia or lability, were 0 (0%) and 44 (35%), respectively. Compared to previously reported hypoglycemia indexes, the low blood glucose index was lower in our study. However, the glycemic lability indexes were similar to those in previous studies, with the exception of the LI. The modified LI and the average daily risk range (ADRR) showed higher concordance with other glycemic lability indexes than did the LI or mean amplitude of glycemic excursions (MAGE). The results showed that the hypoglycemic indexes in this study population were lower than the results from Ryan et al. Furthermore, the ADRR or modified LI were better measures for high risk of severe lability than were the LI and MAGE.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21505268     DOI: 10.1507/endocrj.k11e-014

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  4 in total

Review 1.  Average daily risk range as a measure for clinical research and routine care.

Authors:  Susana R Patton; Mark A Clements
Journal:  J Diabetes Sci Technol       Date:  2013-09-01

Review 2.  Metrics Beyond Hemoglobin A1C in Diabetes Management: Time in Range, Hypoglycemia, and Other Parameters.

Authors:  Lorena Alarcon-Casas Wright; Irl B Hirsch
Journal:  Diabetes Technol Ther       Date:  2017-05       Impact factor: 6.118

Review 3.  Glycemic variability in hospitalized patients: choosing metrics while awaiting the evidence.

Authors:  Susan S Braithwaite
Journal:  Curr Diab Rep       Date:  2013-02       Impact factor: 4.810

Review 4.  Update on biomarkers of glycemic control.

Authors:  Maja Krhač; Marijana Vučić Lovrenčić
Journal:  World J Diabetes       Date:  2019-01-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.